Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
Seoul, South Korea. Responsibilities: • Develop and implement research related to the Health Economics, Outcomes Research & Real-World Evidence business areas (economic modelling, observational studies, systematic reviews & meta-analysis, value communication, pricing & market access strategy). • Develop value-evidence strategies, product value dossiers and value communications for clients. • Design and conduct observational studies: protocol development, methodology/statistical analysis plan, study … Read more
MA / MN, US. We are looking for a highly motivated individual with a strong background in real-world evidence (RWE) and health economics and outcomes research (HEOR) with demonstrated experience of a strategic business mindset. As a member of the Urology business unit’s Strategic Health Economics and Market Access (HEMA) team, you will play a pivotal role in effectively developing … Read more
Mumbai, India. -Leads the development and implementation of the patient access strategy at country level. To facilitate and achieve optimal Patient Access by building relationships with key influencers and decision-makers. About the Role Major accountabilities: Drives decisions related to Market Access (MA)strategy at a local level. Utilizes insights from cross functional teams and market research to launch, develop and implement … Read more
Plainsboro, NJ, US. The Novo Nordisk Real World Evidence (RWE) / Clinical Data Science & Evidence (CDSE) – Fellow is responsible for supporting planning and execution of observational research / Real World Evidence studies to support the Evidence and Insights Generation Plans (EIGPs) for specific areas of the Novo Nordisk portfolio. In addition, the incumbent may also coordinate other activities … Read more
Cambridge, MA, US. This role is responsible for the overall market access strategy for the Global Oncology franchise. This role is instrumental in overseeing and leading the development, integration and implementation of product value propositions, indication/franchise strategy, life cycle management, the pricing & contracting approach and ensuring customer-facing affiliates/countries are appropriately trained and resourced on current strategies for Oncology franchise. … Read more
Bangalore, India. Novo Nordisk, a global healthcare leader, is seeking a Senior Global Project Manager to join our Real-World Evidence Operations team in the Regions & Operations Department of Global Medical Affairs, Global Business Services (GBS), based in Bangalore. Job Description: As a SGlobal Project Manager, Real-World Evidence, you will lead complex, global real-world evidence studies and non-interventional studies. You … Read more
Malaysia / Thailand / Indonesia. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. Locations: Petaling Jaya, Malaysia| Bangkok, Thailand| Jakarta, Indonesia| Remote| Malaysia. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to … Read more
Sintra, Portugal. Prepare product assets for hand-over to launch teams with corresponding market access, pricing and commercial strategies and plans in alignment with local launch governance. Drive and implement a successful Awareness Building & Early Market Access Shaping framework adopting a cross-functional approach including, Value & Access, Medical Affairs and Therapeutic Area (TA). Lead and oversee activities of RWE (Real … Read more
Home-based, US. This position can be based remotely anywhere in the U.S. (there may be some restrictions based on le-gal entity). Please note that this role would not provide relocation as a result. The expectation of working hours and travel (domestic and/or international) will be defined by the hiring manager. This position will require 10% travel. About the Role: This … Read more
Dublin, Ireland. We are seeking a highly skilled and experienced individual to join our team as a Senior HEOR Manager. As the Senior HEOR Manager, you will lead the implementation of a sustainable Patient Access strategy at a local (CPO) level. Your main responsibility will be to collect and analyze data to generate insights for Patient Access submissions that create … Read more
Markham, Canada. This position reports to the Specialty Head, Market access & HEOR. The candidate must reside near Montreal or Markham, as the role adheres adheres to a “3 days in office” policy. Key Responsibilities: Developing market access, health economics & outcomes research strategies to gain / maintain / optimize reimbursement for new and existing products with various public and … Read more
Ireland / UK / India. GBS is the unique trusted network of specialists partnering across all of Novartis delivering high quality services and innovative solutions to enable our enterprise goal of reimagining medicine. The Associate Director will support RWE Executive Directors in developing and executing RWE strategies for molecules within a disease area as well as the execution of Real … Read more
Montreal, Canada. This position reports to the Specialty Head, Market access & HEOR. The candidate must reside near Montreal or Markham, as the role adheres adheres to a “3 days in office” policy. Key Responsibilities: Developing market access, health economics & outcomes research strategies to gain / maintain / optimize reimbursement for new and existing products with various public and … Read more
Montreal, Canada. The Lead for RWE/HEOR and Pipeline Strategy is responsible for defining the vision and strategic direction for Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) in alignment with payer and Health Technology Assessment (HTA) needs. This role oversees the delivery of HEOR outcomes and collaborates closely with Therapeutic Area teams, cross-functional partners, and global teams. As … Read more
Madrid, Spain. ¿Qué buscamos? Necesitamos una persona con gran capacidad de trabajo, capacidad analítica, atención al detalle, iniciativa y flexibilidad a la que le guste trabajar en equipo y que quiera desarrollar su carrera en el área de Acceso al Mercado, para cubrir una vacante en el departamento de Acceso al Mercado y Precios. Se trata de una posición cuya … Read more
Real-World Evidence in Health Economics
Real-World Evidence in Health Economics
Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.
What is Real-World Evidence?
Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.
RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.
Importance of Real-World Evidence in Health Economics
RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.
RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.
Differences between RWE and Randomized Controlled Trials (RCTs)
RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.
RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.
RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.
Methods of Collecting RWE
There are several methods of collecting RWE, including:
Electronic Health Records (EHRs) EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.
Claims Databases Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.
Registries Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.
Patient-Reported Outcomes (PROs) PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.
Surveys Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.
Advantages of Real-World Evidence
There are several advantages of using RWE in health economics research, including:
RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
RWE can be used to evaluate interventions in a variety of settings and patient populations.
RWE can provide information on the long-term effectiveness and safety of interventions.
RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.
Challenges and Limitations of Real-World Evidence
There are several challenges and limitations to using RWE in health economics research, including:
RWE can be subject to bias and confounding, which can affect the validity of the results.
RWE can be difficult to collect and analyze, particularly when using multiple data sources.
RWE may not be as well-suited for evaluating rare diseases or interventions.
Applications of Real-World Evidence
RWE has several applications in health economics research, including:
Health Technology Assessment Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.
Comparative Effectiveness Research Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.
Post-Marketing Surveillance Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.
Future of Real-World Evidence in Health Economics
RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
